Cardiogenic Shock in the Setting of Acute Myocardial Infarction.


Journal

Methodist DeBakey cardiovascular journal
ISSN: 1947-6108
Titre abrégé: Methodist Debakey Cardiovasc J
Pays: United States
ID NLM: 101508600

Informations de publication

Date de publication:
Historique:
entrez: 14 4 2020
pubmed: 14 4 2020
medline: 8 7 2020
Statut: ppublish

Résumé

Cardiogenic shock in the setting of acute myocardial infarction remains a major cause of morbidity and mortality. In fact, acute myocardial infarction accounts for 81% of patients in cardiogenic shock. Despite advances in pharmacologic and device-based approaches to support patients with cardiogenic shock, no significant improvement in mortality has been observed over the past 20 years, although multiple registries are providing new insight into this complex syndrome. Key elements for optimal treatment include integration of hemodynamic and metabolic data for diagnosis and risk stratification, early evaluation and appropriate initiation of acute mechanical circulatory support devices, and an organized algorithmic approach to decision making.

Identifiants

pubmed: 32280413
doi: 10.14797/mdcj-16-1-16
pmc: PMC7137623
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

16-21

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 Houston Methodist Hospital Houston, Texas.

Déclaration de conflit d'intérêts

Conflict of Interest Disclosure: Dr. Kapur is a formal advisor for and conducts research on behalf of Abbott, Abiomed, Boston Scientific, LivaNova, Medtronic, MD Start, and preCARDIA.

Références

N Engl J Med. 2017 Dec 21;377(25):2419-2432
pubmed: 29083953
Am J Cardiol. 1977 Feb;39(2):137-45
pubmed: 835473
Eur J Heart Fail. 2015 May;17(5):501-9
pubmed: 25820680
Circulation. 2018 Nov 13;138(20):e618-e651
pubmed: 30571511
Catheter Cardiovasc Interv. 2019 Jul 1;94(1):29-37
pubmed: 31104355
Am J Cardiol. 1967 Oct;20(4):457-64
pubmed: 6059183
Catheter Cardiovasc Interv. 2018 Feb 15;91(3):454-461
pubmed: 29266676
J Am Heart Assoc. 2014 Jan 13;3(1):e000590
pubmed: 24419737
Catheter Cardiovasc Interv. 2019 Jun 1;93(7):1173-1183
pubmed: 31025538
Circulation. 2016 Jan 26;133(4):e38-360
pubmed: 26673558
J Am Coll Cardiol. 2019 Apr 9;73(13):1659-1669
pubmed: 30947919
N Engl J Med. 1999 Aug 26;341(9):625-34
pubmed: 10460813
JAMA. 2006 Jun 7;295(21):2511-5
pubmed: 16757723
J Am Heart Assoc. 2019 Apr 16;8(8):e011991
pubmed: 30947630
Circ Cardiovasc Qual Outcomes. 2013 Nov;6(6):708-15
pubmed: 24221834

Auteurs

Navin K Kapur (NK)

TUFTS MEDICAL CENTER, BOSTON, MASSACHUSETTS.

Katherine L Thayer (KL)

TUFTS MEDICAL CENTER, BOSTON, MASSACHUSETTS.

Elric Zweck (E)

TUFTS MEDICAL CENTER, BOSTON, MASSACHUSETTS.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH